AI software to find aggressive prostate cancer on MRI
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether an AI program can better spot aggressive prostate cancer on MRI scans, which may help guide treatment decisions. Participation involves having an MRI and possibly a biopsy, and your scan will be analyzed by the software.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have a prostate gland (including transgender women).
- Your doctor has referred you for a prostate MRI because prostate cancer is suspected.
- You have not had a previous prostate biopsy.
- You have never been treated for prostate cancer or benign prostatic hyperplasia (BPH).
- You have no metal implants or other factors that would make an MRI unsafe or poor quality.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This trial studies how AI might improve the process of prostate biopsies for people who have had an MRI. It may help if you are scheduled for a biopsy and have not been treated for prostate cancer before.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.